Exosomes in Viral Disease

Neurotherapeutics

Volumn 13, Issue 3, 2016, Pages 535-546

  Anderson, Monique R ^a,b   Kashanchi, Fatah ^c   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

Author keywords

ESCRT; Exosomes; microvesicles; multivesicular bodies; back fusion

Indexed keywords

VIRUS ANTIGEN;

BIOGENESIS; BUNYAVIRIDAE; CELL COMMUNICATION; CYTOMEGALOVIRUS; EBOLAVIRUS; EPSTEIN BARR VIRUS; EXOSOME; HEPATITIS A VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; MEMBRANE MICROPARTICLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; WART VIRUS; ZIKA VIRUS; BUNYAVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; PAPILLOMAVIRIDAE; PATHOPHYSIOLOGY; PHYSIOLOGY; VIRAL PHENOMENA AND FUNCTIONS; VIROLOGY;

BUNYAVIRIDAE INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; EXOSOMES; HIV INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PAPILLOMAVIRIDAE; VIRUS DISEASES; VIRUS PHYSIOLOGICAL PHENOMENA;

EID: 84975215693     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-016-0450-6     Document Type: Review

References (149)

1. Trams EG, Lauter CJ, Salem N, Jr., Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 1981;645(1):63-70.
2. Johnstone RM, Bianchini A, Teng K. Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood 1989;74(5):1844-1851.
3. Lai FW, Lichty BD, Bowdish DM. Microvesicles: ubiquitous contributors to infection and immunity. J Leukoc Biol 2015;97(2):237-245.
4. Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 2014;14(3):195-208.
5. van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 2012;64(3):676-705.
6. van Dongen HM, Masoumi N, Witwer KW, Pegtel DM. Extracellular vesicles exploit viral entry routes for cargo delivery. Microbiol Mol Biol Rev 2016;80(2):369-386.
7. Schwab A, Meyering SS, Lepene B, et al. Extracellular vesicles from infected cells: potential for direct pathogenesis. Front Microbiol 2015;6:1132.
8. Alenquer M, Amorim MJ. Exosome biogenesis, regulation, and function in viral infection. Viruses 2015;7(9):5066-5083.
9. Chahar HS, Bao X, Casola A. Exosomes and their role in the life cycle and pathogenesis of RNA viruses. Viruses 2015;7(6):3204-3225.
10. Meckes DG, Jr. Exosomal communication goes viral. J Virol 2015;89(10):5200-5203.
11. Wurdinger T, Gatson NN, Balaj L, Kaur B, Breakefield XO, Pegtel DM. Extracellular vesicles and their convergence with viral pathways. Adv Virol 2012;2012:767694.
12. Li XB, Zhang ZR, Schluesener HJ, Xu SQ. Role of exosomes in immune regulation. J Cell Mol Med 2006;10(2):364-375.
13. Blanchard N, Lankar D, Faure F, et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 2002;168(7):3235-3241.
14. Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183(3):1161-1172.
15. Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 1998;273(32):20121-20127.
16. Thery C, Regnault A, Garin J, P et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999;147(3):599-610.
17. Faure J, Lachenal G, Court M, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci 2006;31(4):642-648.
18. Basso M, Bonetto V. Extracellular vesicles and a novel form of communication in the brain. Front Neurosci 2016;10:127.
19. Wang G, Dinkins M, He Q, et al. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 2012;287(25):21384-21395.
20. Walker JD, Maier CL, Pober JS. Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes. J Immunol 2009;182(3):1548-1559.
21. Comelli L, Rocchiccioli S, Smirni S, et al. Characterization of secreted vesicles from vascular smooth muscle cells. Mol Biosyst 2014;10(5):1146-1152.
22. Kramer-Albers EM, Bretz N, Tenzer S, et al. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: Trophic support for axons? Proteomics Clin Appl 2007;1(11):1446-1461.
23. Schorey JS, Cheng Y, Singh PP, Smith VL. Exosomes and other extracellular vesicles in host-pathogen interactions. EMBO Rep 2015;16(1):24-43.
24. Boukouris S, Mathivanan S. Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin Appl 2015;9(3-4):358-367.
25. Yang T, Martin P, Fogarty B, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res 2015;32(6):2003-2014.
26. El Andaloussi S, Lakhal S, Mager I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev 2013;65(3):391-397.
27. Murk JL, Stoorvogel W, Kleijmeer MJ, Geuze HJ. The plasticity of multivesicular bodies and the regulation of antigen presentation. Semin Cell Develop Biol 2002;13(4):303-311.
28. Bissig C, Gruenberg J. ALIX and the multivesicular endosome: ALIX in Wonderland. Trends Cell Biol 2014;24(1):19-25.
29. Pegtel DM, van de Garde MD, Middeldorp JM. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim Biophys Acta 2011;1809(11-12):715-721.
30. Matsuo H, Chevallier J, Mayran N, et al. Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science 2004;303(5657):531-534.
31. Nour AM, Modis Y. Endosomal vesicles as vehicles for viral genomes. Trends Cell Biol 2014;24(8):449-454.
32. Meckes DG, Jr., Raab-Traub N. Microvesicles and viral infection. J Virol 2011;85(24):12844-12854.
33. Gan X, Gould SJ. Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins. Mol Biol Cell 2011;22(6):817-830.
34. Sampey GC, Meyering SS, Asad Zadeh M, Saifuddin M, Hakami RM, Kashanchi F. Exosomes and their role in CNS viral infections. J Neurovirol 2014;20(3):199-208.
35. Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012;10(12):e1001450.
36. Kim DK, Kang B, Kim OY, et al. EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles 2013;2.
37. Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008;319(5867):1244-1247.
38. van Niel G, Charrin S, Simoes S, et al. The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. Develop Cell 2011;21(4):708-721.
39. Perez-Hernandez D, Gutierrez-Vazquez C, Jorge I, et al. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J Biol Chem 2013;288(17):11649-11661.
40. Stuffers S, Sem Wegner C, Stenmark H, Brech A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 2009;10(7):925-937.
41. Tamai K, Tanaka N, Nakano T, et al. Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. Biochem Biophys Res Commun 2010;399(3):384-390.
42. Schwartz SL, Cao C, Pylypenko O, Rak A, Wandinger-Ness A. Rab GTPases at a glance. J Cell Sci 2007;120(Pt 22):3905-3910.
43. Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010;12(1):19-30.
44. Savina A, Fader CM, Damiani MT, Colombo MI. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 2005;6(2):131-143.
45. Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Develop Biol 2014;30:255-289.
46. Fader CM, Sanchez DG, Mestre MB, Colombo MI. TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. Biochim Biophys Acta 2009;1793(12):1901-1916.
47. Montecalvo A, Shufesky WJ, Stolz DB, et al. Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J Immunol 2008;180(5):3081-3090.
48. Lagana A, Russo F, Veneziano D, et al. Extracellular circulating viral microRNAs: current knowledge and perspectives. Front Genet 2013;4:120.
49. Thebaud B, Stewart DJ. Exosomes: cell garbage can, therapeutic carrier, or trojan horse? Circulation 2012;126(22):2553-2555.
50. Morelli AE, Larregina AT, Shufesky WJ, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 2004;104(10):3257-3266.
51. Segura E, Guerin C, Hogg N, Amigorena S, Thery C. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol 2007;179(3):1489-1496.
52. Thery C, Duban L, Segura E, Veron P, Lantz O, Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 2002;3(12):1156-1162.
53. Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, et al. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int Immunol 2002;14(7):713-722.
54. Admyre C, Johansson SM, Paulie S, Gabrielsson S. Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur J Immunol 2006;36(7):1772-1781.
55. Segura E, Nicco C, Lombard B, et al. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 2005;106(1):216-223.
56. Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001;7(3):297-303.
57. Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 2014;3.
58. Okoye IS, Coomes SM, Pelly VS, et al. MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity 2014;41(1):89-103.
59. Zakharova L, Svetlova M, Fomina AF. T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor. J Cell Physiol 2007;212(1):174-181.
60. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007;450(7168):435-439.
61. Feng D, Zhao WL, Ye YY, et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic 2010;11(5):675-687.
62. Moller-Tank S, Maury W. Phosphatidylserine receptors: enhancers of enveloped virus entry and infection. Virology 2014;468-470:565-80.
63. Rhein BA, Brouillette RB, Schaack GA, Chiorini JA, Maury W. Characterization of human and murine T-cell immunoglobulin mucin domain 4 (TIM-4) IgV domain residues critical for Ebola virus entry. J Virol 2016 Apr 27.
64. Smit JM, Moesker B, Rodenhuis-Zybert I, Wilschut J. Flavivirus cell entry and membrane fusion. Viruses 2011;3(2):160-171.
65. Hamel R, Dejarnac O, Wichit S, et al. Biology of Zika virus infection in human skin cells. J Virol 2015;89(17):8880-8896.
66. Nour AM, Li Y, Wolenski J, Modis Y. Viral membrane fusion and nucleocapsid delivery into the cytoplasm are distinct events in some flaviviruses. PLoS Pathog 2013;9(9):e1003585.
67. Cohen FS. How viruses invade cells. Biophys J 2016;110(5):1028-1032.
68. Ramakrishnaiah V, Thumann C, Fofana I, et al. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci U S A 2013;110(32):13109-13113.
69. Longatti A, Boyd B, Chisari FV. Virion-independent transfer of replication-competent hepatitis C virus RNA between permissive cells. J Virol 2015;89(5):2956-2961.
70. Longatti A. The dual role of exosomes in hepatitis A and C virus transmission and viral immune activation. Viruses 2015;7(12):6707-6715.
71. Izquierdo-Useros N, Naranjo-Gomez M, Erkizia I, et al. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLoS Pathog 2010;6(3):e1000740.
72. Gould SJ, Booth AM, Hildreth JE. The Trojan exosome hypothesis. Proc Natl Acad Sci U S A 2003;100(19):10592-10597.
73. Wiley RD, Gummuluru S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci U S A 2006;103(3):738-743.
74. Piguet V, Steinman RM. The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol 2007;28(11):503-510.
75. Yandrapalli N, Muriaux D, Favard C. Lipid domains in HIV-1 assembly. Front Microbiol 2014;5:220.
76. Woodward CL, Cheng SN, Jensen GJ. Electron cryotomography studies of maturing HIV-1 particles reveal the assembly pathway of the viral core. J Virol 2015;89(2):1267-1277.
77. Madison MN, Okeoma CM. Exosomes: implications in HIV-1 pathogenesis. Viruses 2015;7(7):4093-4118.
78. Mori Y, Koike M, Moriishi E, et al. Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 2008;9(10):1728-1742.
79. Bruce EA, Digard P, Stuart AD. The Rab11 pathway is required for influenza A virus budding and filament formation. J Virol 2010;84(12):5848-5859.
80. Rowe RK, Suszko JW, Pekosz A. Roles for the recycling endosome, Rab8, and Rab11 in hantavirus release from epithelial cells. Virology 2008;382(2):239-249.
81. Utley TJ, Ducharme NA, Varthakavi V, et al. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci U S A 2008;105(29):10209-10214.
82. Fraile-Ramos A, Cepeda V, Elstak E, van der Sluijs P. Rab27a is required for human cytomegalovirus assembly. PLoS One 2010;5(12):e15318.
83. Gerber PP, Cabrini M, Jancic C, et al. Rab27a controls HIV-1 assembly by regulating plasma membrane levels of phosphatidylinositol 4,5-bisphosphate. J Cell Biol 2015;209(3):435-452.
84. Meng B, Ip NC, Prestwood LJ, Abbink TE, Lever AM. Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production. Retrovirology 2015;12:72.
85. Lenassi M, Cagney G, Liao M, et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 2010;11(1):110-122.
86. Bello-Morales R, Crespillo AJ, Fraile-Ramos A, Tabares E, Alcina A, Lopez-Guerrero JA. Role of the small GTPase Rab27a during herpes simplex virus infection of oligodendrocytic cells. BMC Microbiol 2012;12:265.
87. Krummenacher C, Carfi A, Eisenberg RJ, Cohen GH. Entry of herpesviruses into cells: the enigma variations. Adv Exp Med Biol 2013;790:178-195.
88. Narayanan A, Iordanskiy S, Das R, et al. Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA. J Biol Chem 2013;288(27):20014-20033.
89. Sampey GC, Saifuddin M, Schwab A, et al. Exosomes from HIV-1-infected cells stimulate production of pro-inflammatory cytokines through trans-activating response (TAR) RNA. J Biol Chem 2016;291(3):1251-1266.
90. Jaworski E, Saifuddin M, Sampey G, et al. The use of Nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells. PLoS One 2014;9(5):e96778.
91. Campbell TD, Khan M, Huang MB, Bond VC, Powell MD. HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn Dis 2008;18(2 Suppl. 2):S2-14-9.
92. Arenaccio C, Chiozzini C, Columba-Cabezas S, et al. Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism. J Virol 2014;88(19):11529-11539.
93. Arenaccio C, Anticoli S, Manfredi F, Chiozzini C, Olivetta E, Federico M. Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1. Retrovirology 2015;12:87.
94. de Carvalho JV, de Castro RO, da Silva EZ, et al. Nef neutralizes the ability of exosomes from CD4+ T cells to act as decoys during HIV-1 infection. PLoS One 2014;9(11):e113691.
95. Luo X, Fan Y, Park IW, He JJ. Exosomes are unlikely involved in intercellular Nef transfer. PLoS One 2015;10(4):e0124436.
96. Ali SA, Huang MB, Campbell PE, et al. Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res Hum Retroviruses 2010;26(2):173-192.
97. Campbell PE, Isayev O, Ali SA, et al. Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling. J Mol Model 2012;18(10):4603-4613.
98. Jaworski E, Narayanan A, Van Duyne R, et al. Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein. J Biol Chem 2014;289(32):22284-22305.
99. Romanelli MG, Diani E, Bergamo E, et al. Highlights on distinctive structural and functional properties of HTLV Tax proteins. Front Microbiol 2013;4:271.
100. Currer R, Van Duyne R, Jaworski E, et al. HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways. Front Microbiol 2012;3:406.
101. Shembade N, Harhaj EW. Role of post-translational modifications of HTLV-1 Tax in NF-kappaB activation. World J Biol Chem 2010;1(1):13-20.
102. Alefantis T, Mostoller K, Jain P, Harhaj E, Grant C, Wigdahl B. Secretion of the human T cell leukemia virus type I transactivator protein tax. J Biol Chem 2005;280(17):17353-17362.
103. Alefantis T, Jain P, Ahuja J, Mostoller K, Wigdahl B. HTLV-1 Tax nucleocytoplasmic shuttling, interaction with the secretory pathway, extracellular signaling, and implications for neurologic disease. J Biomed Sci 2005;12(6):961-974.
104. Cowan EP, Alexander RK, Daniel S, Kashanchi F, Brady JN. Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax. J Virol 1997;71(9):6982-6989.
105. Dhib-Jalbut S, Hoffman PM, Yamabe T, et al. Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells. Ann Neurol 1994;36(5):787-790.
106. Lepoutre V, Jain P, Quann K, Wigdahl B, Khan ZK. Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease. Front Biosci 2009;14:1152-1168.
107. Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. AIDS Res Hum Retroviruses 2000;16(16):1705-1709.
108. Levin MC, Lee SM, Morcos Y, Brady J, Stuart J. Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry. J Infect Dis 2002;186(10):1514-1517.
109. Irish BP, Khan ZK, Jain P, et al. Molecular mechanisms of neurodegenerative diseases induced by human retroviruses: a review. Am J Infect Dis 2009;5(3):231-258.
110. Rixon FJ, Addison C, McLauchlan J. Assembly of enveloped tegument structures (L particles) can occur independently of virion maturation in herpes simplex virus type 1-infected cells. J Gen Virol 1992;73(Pt 2):277-284.
111. McLauchlan J, Rixon FJ. Characterization of enveloped tegument structures (L particles) produced by alphaherpesviruses: integrity of the tegument does not depend on the presence of capsid or envelope. J Gen Virol 1992;73(Pt 2):269-276.
112. McLauchlan J, Addison C, Craigie MC, Rixon FJ. Noninfectious L-particles supply functions which can facilitate infection by HSV-1. Virology 1992;190(2):682-688.
113. Heilingloh CS, Kummer M, Muhl-Zurbes P, et al. L particles transmit viral proteins from herpes simplex virus 1-infected mature dendritic cells to uninfected bystander cells, inducing CD83 downmodulation. J Virol 2015;89(21):11046-11055.
114. Kalamvoki M, Deschamps T. Extracellular vesicles during Herpes Simplex Virus type 1 infection: an inquire. Virol J 2016;13(1):63.
115. Kalamvoki M, Du T, Roizman B. Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs. Proc Natl Acad Sci U S A 2014;111(46):E4991-E4996.
116. Temme S, Eis-Hubinger AM, McLellan AD, Koch N. The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J Immunol. 2010;184(1):236-243.
117. Lee CP, Liu PT, Kung HN, et al. The ESCRT machinery is recruited by the viral BFRF1 protein to the nucleus-associated membrane for the maturation of Epstein-Barr Virus. PLoS Pathog 2012;8(9):e1002904.
118. Flanagan J, Middeldorp J, Sculley T. Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J Gen Virol 2003;84(Pt 7):1871-1879.
119. Dukers DF, Meij P, Vervoort MB, et al. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 2000;165(2):663-670.
120. Nanbo A, Kawanishi E, Yoshida R, Yoshiyama H. Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. J Virol 2013;87(18):10334-10347.
121. Klibi J, Niki T, Riedel A, et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 2009;113(9):1957-1966.
122. Meckes DG, Jr., Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A 2010;107(47):20370-20375.
123. Ansari MA, Singh VV, Dutta S, et al. Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. J Virol 2013;87(15):8606-8623.
124. Baglio SR, van Eijndhoven MA, Koppers-Lalic D, et al. Sensing of latent EBV infection through exosomal transfer of 5'pppRNA. Proc Natl Acad Sci U S A 2016;113(5):E587-E596.
125. Chugh PE, Sin SH, Ozgur S, et al. Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLoS Pathog 2013;9(7):e1003484.
126. Naranatt PP, Krishnan HH, Svojanovsky SR, Bloomer C, Mathur S, Chandran B. Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res 2004;64(1):72-84.
127. Meckes DG, Jr., Gunawardena HP, Dekroon RM, et al. Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc Natl Acad Sci U S A 2013;110(31):E2925-E2933.
128. Kuo HT, Ye X, Sampaio MS, Reddy P, Bunnapradist S. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis. Transplantation 2010;90(10):1091-1098.
129. McDevitt LM. Etiology and impact of cytomegalovirus disease on solid organ transplant recipients. Am J Health Syst Pharm 2006;63(19 Suppl. 5):S3-S9.
130. Roux A, Mourin G, Fastenackels S, et al. CMV driven CD8(+) T-cell activation is associated with acute rejection in lung transplantation. Clin Immunol 2013;148(1):16-26.
131. Plazolles N, Humbert JM, Vachot L, Verrier B, Hocke C, Halary F. Pivotal advance: The promotion of soluble DC-SIGN release by inflammatory signals and its enhancement of cytomegalovirus-mediated cis-infection of myeloid dendritic cells. J Leukoc Biol 2011;89(3):329-342.
132. Halary F, Amara A, Lortat-Jacob H, et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002;17(5):653-664.
133. Ota M, Serada S, Naka T, Mori Y. Expression of MHC class I molecule in HHV-6B-infected cells. Microbiol Immunol 2014;58(2):Februarycover.
134. Wang X, Wang HK, Li Y, et al. microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A 2014;111(11):4262-4267.
135. Honegger A, Schilling D, Bastian S, et al. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog 2015;11(3):e1004712.
136. Melo SA, Sugimoto H, O'Connell JT, et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 2014;26(5):707-721.
137. Feng Z, Hensley L, McKnight KL, et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 2013;496(7445):367-371.
138. Feng Z, Li Y, McKnight KL, et al. Human pDCs preferentially sense enveloped hepatitis A virions. J Clin Invest 2015;125(1):169-176.
139. Chai N, Chang HE, Nicolas E, Han Z, Jarnik M, Taylor J. Properties of subviral particles of hepatitis B virus. J Virol 2008;82(16):7812-7817.
140. Ahsan NA, Sampey GC, Lepene B, et al. Presence of viral RNA and proteins in exosomes from cellular clones resistant to Rift Valley fever virus infection. Front Microbiol 2016;7:139.
141. Silvas JA, Popov VL, Paulucci-Holthauzen A, Aguilar PV. Extracellular vesicles mediate receptor-independent transmission of novel tick-borne Bunyavirus. J Virol 2016;90(2):873-886.
142. Lozach PY, Kuhbacher A, Meier R, et al. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 2011;10(1):75-88.
143. Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 2015;372(25):2423-2427.
144. Uyeki TM, Erickson BR, Brown S, et al. Ebola virus persistence in semen of male survivors. Clin Infect Dis 2016;62:1552-1555.
145. Atkinson B, Hearn P, Afrough B, et al. Detection of Zika virus in semen. Emerg Infect Dis 2016;22(5):940.
146. Malkki H. CNS infections: Zika virus infection could trigger Guillain-Barre syndrome. Nat Rev Neurol 2016;12(4):187.
147. Garcez PP, Loiola EC, Madeiro da Costa R, et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 2016;352:816-818.
148. Williamson PR, Nash TE, Williamson KC, Nath A. CNS infections in 2015: emerging catastrophic infections and new insights into neuroimmunological host damage. Lancet Neurol 2016;15(1):17-19.
149. Han Z, Madara JJ, Liu Y, et al. ALIX rescues budding of a double PTAP/PPEY L-domain deletion mutant of Ebola VP40: a role for ALIX in Ebola virus egress. J Infect Dis 2015;212(Suppl. 2):S138-S145.